Convergence Investment Partners’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.44M Sell
8,044
-2,201
-21% -$376K 0.24% 155
2025
Q4
$1.45M Buy
+10,245
New +$1.16M 0.29% 121
2023
Q1
Sell
-756
Closed -$164K 181
2022
Q4
$164K Buy
756
+94
+14% +$25.1K 0.1% 176
2022
Q3
$175K Buy
+662
New +$168K 0.11% 169
2015
Q1
Sell
-51,038
Closed -$3.07M 361
2014
Q4
$3.07M Buy
51,038
+13,390
+36% +$789K 0.41% 73
2014
Q3
$2.22M Buy
+37,648
New +$2.45M 0.3% 128

Other funds holding ALB

Convergence Investment Partners's ALB Position: Q1 2026 in Review

Convergence Investment Partners reduced its Albemarle (ALB) stake by 21% in Q1 2026, selling an estimated $376K and leaving 8,044 shares worth $1.44M. The position accounts for 0.24% of the portfolio, ranked #155.

Convergence Investment Partners first reported a position in ALB in Q3 2014 and has held it in 6 quarters since. The position peaked at $3.07M in Q4 2014. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • Convergence Investment Partners held 8,044 shares of Albemarle worth $1.44M as of Q1 2026.
  • Convergence Investment Partners sold 2,201 Albemarle shares in Q1 2026, an estimated $376K.
  • Albemarle made up 0.24% of Convergence Investment Partners's portfolio in Q1 2026, its #155 holding.
  • Convergence Investment Partners first reported a position in Albemarle in Q3 2014 and has held it in 6 quarters since.
  • Convergence Investment Partners's Albemarle position peaked at $3.07M in Q4 2014.
  • 982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Convergence Investment Partners's 13F filing for Q1 2026, filed 7 May 2026.